• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM ASD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® CARDIOFORM ASD OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number ASD37A
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Thrombosis/Thrombus (4440)
Date of Event 03/01/2023
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
A review of the manufacturing and sterilization records for the device verified that the lot met all pre-release specifications.The imaging report stated the following: it was reported the physician implanted a 37mm gore® cardioform asd.On a 3-day post follow up tee, thrombus was visualized on the right atrial disc.From the limited imaging provided the gore cardioform asd occluder is visualized in a good position.The left and right discs appear to be on the appropriate sides of the atrial septum.An echogenic mass is visualized on the right atrial disc.The appearance of this mass is consistent with that of thrombus.The physician used a thrombectomy system to remove the clot from the device.It appears from the imaging that the clot was removed successfully, and the device remained in a satisfactory position, however, without additional imaging this cannot be confirmed.Per the physician the patient is doing well.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event or Problem Description
It was reported the physician implanted a 37mm gore® cardioform asd occluder on (b)(6)2023.Two days following implant the patient complained of fever.On (b)(6) 2023, an echogenic mass (suspected thrombus) was noted on the right disc using transthoracic echocardiography.The patient was treated with an unknown anticoagulant, and blood cultures were negative.The next day, on transesophageal echocardiography the thrombus was confirmed on the right disc and a thrombectomy was performed to remove the thrombus.The device remains implanted, and the patient was doing well following the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® CARDIOFORM ASD OCCLUDER
Common Device Name
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
dan kitterman
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key16598513
Report Number2017233-2023-03812
Device Sequence Number4511881
Product Code MLV
UDI-Device Identifier00733132636501
UDI-Public00733132636501
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
P050006
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 03/23/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date02/28/2025
Device Model NumberASD37A
Device Catalogue NumberASD37A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/02/2023
Initial Report FDA Received Date03/23/2023
Date Device Manufactured03/02/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age69 YR
Patient SexMale
Patient Weight88 KG
-
-